1Shibata N, Nagai R, Miyata S, et al. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase 1 mutation. Acta Neuropathol. 2000; 100(3):275-284.
2Shibata N, Yamada S, Uchida K ,et al. Accumulation of protein-bound d-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Brain Res. 2004,1019(1 - 2) : 170-177.
3Shibata N, Kawaguchi M, Uchida K,et al. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model. Neuropathology. 2007 ,27(1) :49-61.
4Beal MF,Ferrante RJ,Browne SE,et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 1997,42(4) :644-654.
5Tohgi H,Abe T, Yamayaki K, et al. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1999;46(1):129-131.
6Carri MT, Ferri A, Cozzolino M, et al. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 2003;61 (4) :365-374.
7Tokuda E,Ono S,lshige K,et al. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicology. 2007;229(1 - 2) :33-41.
8Kasarskis EJ ,Tandon L,Lovell MA,et al. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy : A preliminary study. J Neurol Sci. 1995;130(2) : 203-208.
9Evert CA, Veldman H, Sodaar P, et al. Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons, J Neurosci Res. 1998;54(6) : 778-786.
10Lederer CW, Torrisi A, Pantelidou M,et al. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007 23;8:26.
